Clinical trials
Community-Acquired Pneumonia trials in Italy
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
17 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2006 | 1 |
| 2008 | 1 |
| 2009 | 1 |
| 2011 | 2 |
| 2012 | 1 |
| 2014 | 1 |
| 2016 | 2 |
| 2018 | 1 |
| 2020 | 2 |
| 2021 | 1 |
| 2022 | 1 |
| 2025 | 3 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 7 |
| Recruiting | 4 |
| Unknown status | 4 |
| Enrolling by invitation | 1 |
| Terminated | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| University of Milan | 4 |
| Azienda Ospedaliero-Universitaria Careggi | 2 |
| University of Roma La Sapienza | 2 |
| AstraZeneca | 1 |
| Azienda Ospedaliera, Universitaria Policlinico Vittorio Emanuele | 1 |
| Bayer | 1 |
| Joan Sabater-Riera | 1 |
| Pfizer | 1 |
| Societa Italiana di Pneumologia | 1 |
| UMC Utrecht | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Community-Acquired Pneumonia | 17 |
| Pneumonia | 10 |
| COVID-19 | 2 |
| Communicable Diseases | 2 |
| Community-Acquired Infections | 2 |
| Emergencies | 2 |
| Healthcare-Associated Pneumonia | 2 |
| Pneumonia, Bacterial | 2 |
| Respiratory Tract Infections | 2 |
| Acute Lung Injury | 1 |
Trials
Showing 26 to 17 of 17. Each trial links to its page on Pharma Observatory.
No trials match these filters.
Try a different keyword, or clear a filter.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.